RxDoctor Payments Data

Abdi Morovati, DO

Neurology · Beverly Hills, CANPI 1417000563

Payments from drug & device makers

$16,048in general payments, 2019–2025

Across 734 payments — averaging $21.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Upsher-smith Laboratories LLC$1K
  • Amneal Pharmaceuticals LLC$1K
  • Sanofi$914
  • Novartis$914
  • Neurocrine Biosciences, Inc.$749
  • plus $8K from 51 others

What the payments were for

  • Speaking & faculty fees$821%
  • Food & beverage$15,95399%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)134$2,915
Upsher-smith Laboratories LLC74$1,073
Amneal Pharmaceuticals LLC44$1,065
Sanofi35$914
Novartis41$914
Neurocrine Biosciences, Inc.31$749
Teva Pharmaceuticals USA, Inc.35$735
Amgen(2 entities)31$726
SK Life Science, Inc.30$683
Lilly USA, LLC26$663
Lundbeck LLC31$593
UCB, Inc.21$491
Eisai Inc.13$392
Pfizer19$342
Kyowa Kirin, Inc.17$326
Biohaven Pharmaceutical Holding Company Ltd.16$307
Acadia Pharmaceuticals Inc13$296
Biohaven Pharmaceuticals, Inc.12$242
Biogen9$218
AstraZeneca5$201
Argenx US, Inc.7$166
MDD US Operations, LLC5$125
Promius Pharma LLC5$125
Alnylam Pharmaceuticals Inc.5$106
EMD Serono, Inc.6$100
Sunovion Pharmaceuticals Inc.5$95
Avanir Pharmaceuticals, Inc.4$93
CSL Behring4$90
Acorda Therapeutics, Inc4$82
Bausch Health US, LLC3$82
Tanabe Pharma America, Inc.3$73
Johnson & Johnson(2 entities)3$72
Forte Bio-pharma LLC3$71
Neurelis, Inc.2$70
Ipsen Biopharmaceuticals, Inc3$70
Tonix Medicines, Inc.3$61
Impel Pharmaceuticals Inc.3$61
Vertical Pharmaceuticals, LLC3$56
Greenwich Biosciences, Inc.2$55
GE HealthCare2$55
Sumitomo Pharma America, Inc.3$53
Mallinckrodt Hospital Products Inc.2$50
Abbott2$44
Cycle Pharmaceuticals Inc1$33
Vertex1$32
Genentech USA, Inc.1$32
Assertio Therapeutics, Inc.2$30
Mallinckrodt Enterprises LLC1$27
Otsuka America Pharmaceutical, Inc.1$26
Axsome Therapeutics, Inc.1$26
Supernus Pharmaceuticals, Inc.1$25
Grifols USA, LLC1$24
Catalyst Pharmaceuticals, Inc.1$23
ANI Pharmaceuticals, Inc.1$21
Neuronetics, Inc.1$18
Exact Sciences1$18
Collegium Pharmaceutical, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,048 in reported general payments places this provider in the 75th percentile of 1,996 neurology providers in California.

See all neurology providers in California

Medicare billing

Part B allowed, 2024
$28,633
Medicare patients
105
Services billed
174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Donepezil Hcl43$556
Memantine Hcl22$461
Pregabalin12$391
Gabapentin25$363
Propranolol Hcl12$266
Primidone11$138

Paid to pharmacies, not to this prescriber.

Other neurology in Beverly Hills

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →